## BACKGROUND. CA 125 is a tumor marker used for the diagnosis and monitoring of ovarian carcinoma. This marker also has been found to be increased in patients with serosal effusion derived from nonneoplastic inflammatory disease and in a few instances of advanced non-Hodgkin lymphoma with serosal
Increased serum diphenylamine reaction in patients with leukemia
β Scribed by T. F. Slater; D. Lovell
- Book ID
- 112705542
- Publisher
- Springer
- Year
- 1961
- Tongue
- English
- Weight
- 433 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1420-682X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The serum complement level was studied in 94 cases of patients with myelogenous and lymphogenous leukemia, including long-term survivors. Studies on serial changes in the serum complement level at exacerbation stage and at remission stage in I0 patients with acute leukemia were carried out separatel
## Abstract The white blood cell count response was documented in various patients following transfusions of 500 ml of autologous or unrelated donor blood that had been subjected to 10 minutes of dialysis with 15 minutes of stagnation. Patients studied included 1 patient with acute nonlymphocytic (